Prediction of the treatment response in ovarian cancer: a ctDNA approach.
Circulating tumor DNA
Ovarian cancer
Prognosis
Journal
Journal of ovarian research
ISSN: 1757-2215
Titre abrégé: J Ovarian Res
Pays: England
ID NLM: 101474849
Informations de publication
Date de publication:
19 Oct 2020
19 Oct 2020
Historique:
received:
22
07
2020
accepted:
11
10
2020
entrez:
20
10
2020
pubmed:
21
10
2020
medline:
24
7
2021
Statut:
epublish
Résumé
Ovarian cancer is the eighth most commonly occurring cancer in women. Clinically, the limitation of conventional screening and monitoring approaches inhibits high throughput analysis of the tumor molecular markers toward prediction of treatment response. Recently, analysis of liquid biopsies including circulating tumor DNA (ctDNA) open new way toward cancer diagnosis and treatment in a personalized manner in various types of solid tumors. In the case of ovarian carcinoma, growing pre-clinical and clinical studies underscored promising application of ctDNA in diagnosis, prognosis, and prediction of treatment response. In this review, we accumulate and highlight recent molecular findings of ctDNA analysis and its associations with treatment response and patient outcome. Additionally, we discussed the potential application of ctDNA in the personalized treatment of ovarian carcinoma. ctDNA-monitoring usage during the ovarian cancer treatments procedures.
Identifiants
pubmed: 33076944
doi: 10.1186/s13048-020-00729-1
pii: 10.1186/s13048-020-00729-1
pmc: PMC7574472
doi:
Substances chimiques
Circulating Tumor DNA
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
124Références
Gynecol Oncol. 2004 Oct;95(1):9-15
pubmed: 15385104
Biomarkers. 2013 Sep;18(6):532-41
pubmed: 23902290
Proc Natl Acad Sci U S A. 2005 May 24;102(21):7677-82
pubmed: 15890779
Lancet Oncol. 2011 Nov;12(12):1169-74
pubmed: 21742554
Theranostics. 2019 May 31;9(14):4130-4140
pubmed: 31281536
Neoplasma. 2003;50(1):41-6
pubmed: 12687277
Oncogene. 2015 Jul;34(27):3605-16
pubmed: 25263447
J Thorac Dis. 2018 Jun;10(Suppl 14):S1645-S1651
pubmed: 30034830
J Biol Chem. 2016 Mar 25;291(13):7017-28
pubmed: 26797126
Clin Cancer Res. 2017 May 1;23(9):2223-2231
pubmed: 27852697
Tumour Biol. 2020 May;42(5):1010428320919198
pubmed: 32364828
Neoplasia. 2014 Jan;16(1):97-103
pubmed: 24563622
BMC Med. 2017 Apr 6;15(1):75
pubmed: 28381299
Cancer Treat Res. 2009;149:189-202
pubmed: 19763437
Br J Cancer. 2008 Oct 7;99(7):1103-13
pubmed: 18766180
Eur Cytokine Netw. 2011 Mar;22(1):45-51
pubmed: 21411409
Clin Cancer Res. 2017 May 1;23(9):2213-2222
pubmed: 27663594
Diagn Mol Pathol. 2008 Mar;17(1):34-8
pubmed: 18303408
Mol Cancer Res. 2018 May;16(5):813-824
pubmed: 29523763
Medicines (Basel). 2018 Feb 01;5(1):
pubmed: 29389895
J Ovarian Res. 2014 Dec 05;7:109
pubmed: 25477184
Oncol Lett. 2016 Apr;11(4):2815-2819
pubmed: 27073557
Clin Cancer Res. 2017 Nov 1;23(21):6708-6720
pubmed: 28765325
Oncol Lett. 2020 Apr;19(4):2713-2720
pubmed: 32218822
Front Genet. 2019 Nov 21;10:1118
pubmed: 31824558
Clin Pharmacol Ther. 2010 Jul;88(1):34-8
pubmed: 20520606
Int J Gynecol Cancer. 2016 Jan;26(1):43-51
pubmed: 26588231
Ther Adv Med Oncol. 2018 Aug 29;10:1758835918794630
pubmed: 30181785
Sci Rep. 2016 Jul 20;6:29831
pubmed: 27436510
Am J Physiol Renal Physiol. 2006 Sep;291(3):F567-77
pubmed: 16638913
PLoS Med. 2016 Dec 20;13(12):e1002198
pubmed: 27997533
Nature. 2013 May 2;497(7447):108-12
pubmed: 23563269
Int J Gynecol Cancer. 2011 Jul;21(5):852-8
pubmed: 21633297
Nature. 2015 May 28;521(7553):489-94
pubmed: 26017449
Obstet Gynecol. 2010 Aug;116(2 Pt 1):246-247
pubmed: 20664381
J Ovarian Res. 2015 May 03;8:27
pubmed: 25935153
BMC Cancer. 2015 Mar 11;15:117
pubmed: 25886033
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
Cochrane Database Syst Rev. 2018 Oct 16;10:CD007927
pubmed: 30321910
BMC Clin Pathol. 2013 May 22;13:15
pubmed: 23697837
Oncogene. 2017 Jul 20;36(29):4089-4099
pubmed: 28319068
Int J Cancer. 2010 Aug 15;127(4):977-88
pubmed: 20013802
J Obstet Gynaecol Res. 2006 Jun;32(3):309-14
pubmed: 16764622
Cancer Discov. 2016 May;6(5):479-91
pubmed: 26969689
Cancer Res. 1977 Mar;37(3):646-50
pubmed: 837366
Int J Gynecol Pathol. 2012 Nov;31(6):517-23
pubmed: 23018214
J Ovarian Res. 2009 Oct 09;2:13
pubmed: 19818123
Anticancer Res. 2012 Aug;32(8):3467-71
pubmed: 22843932
J Clin Oncol. 2005 Mar 1;23(7):1463-72
pubmed: 15735122
Sci Rep. 2019 Nov 22;9(1):17358
pubmed: 31758080
Bull Exp Biol Med. 2014 Mar;156(5):684-8
pubmed: 24770758
Cancer Biol Ther. 2006 Oct;5(10):1369-74
pubmed: 16969071
Nat Cancer. 2020 Sep;1(9):873-881
pubmed: 35121950
Obstet Gynecol Sci. 2018 May;61(3):328-336
pubmed: 29780774
Am J Obstet Gynecol. 2009 Jun;200(6):639.e1-5
pubmed: 19285648
J Ovarian Res. 2017 Nov 13;10(1):75
pubmed: 29132396
Hum Pathol. 2016 Nov;57:1-6
pubmed: 27349304
Gynecol Oncol. 2008 Feb;108(2):402-8
pubmed: 18061248
Eur J Gynaecol Oncol. 2010;31(1):63-71
pubmed: 20349783
J Clin Oncol. 2017 Apr 20;35(12):1274-1280
pubmed: 28414925
Clin Chem Lab Med. 2002 Dec;40(12):1320-4
pubmed: 12553437
Oncotarget. 2017 Jun 16;8(32):53432-53449
pubmed: 28881822
Cancer Discov. 2019 Feb;9(2):210-219
pubmed: 30425037
Gynecol Oncol. 2018 Aug;150(2):355-360
pubmed: 29807696
Diagnostics (Basel). 2018 May 09;8(2):
pubmed: 29747380
Int J Mol Sci. 2017 Jul 21;18(7):
pubmed: 28754000
Cancer. 2009 Mar 1;115(5):1028-35
pubmed: 19156927
Clin Chem. 2011 Nov;57(11):1534-44
pubmed: 21933899
Cancer Biol Ther. 2008 Jul;7(7):1098-103
pubmed: 18443431
Cancer Res. 1991 Jun 15;51(12):3237-42
pubmed: 1645616
Phys Med Biol. 2018 Aug 06;63(15):155020
pubmed: 30010611
Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):662-7
pubmed: 16150257
Ann N Y Acad Sci. 2008 Aug;1137:218-21
pubmed: 18837950
Clin Cancer Res. 2004 Jul 1;10(13):4420-6
pubmed: 15240532
Cancer. 2010 Apr 15;116(8):1918-25
pubmed: 20166213
Mol Genet Genomic Med. 2018 May 24;:
pubmed: 29797793
BMC Cancer. 2009 Jun 25;9:201
pubmed: 19555470
Clin Cancer Res. 2015 Oct 15;21(20):4586-96
pubmed: 26085511
J Gynecol Obstet Hum Reprod. 2018 Jun;47(6):227-230
pubmed: 29609043
Sci Transl Med. 2014 Feb 19;6(224):224ra24
pubmed: 24553385
Mol Cell Biochem. 2014 Jan;386(1-2):259-69
pubmed: 24141793
Sci Rep. 2018 Jul 25;8(1):11205
pubmed: 30046040
Cancer J. 2018 Mar/Apr;24(2):93-103
pubmed: 29601336
Mol Clin Oncol. 2014 Jul;2(4):559-566
pubmed: 24940495
Exp Cell Res. 2005 May 15;306(1):128-41
pubmed: 15878339
PLoS One. 2015 May 07;10(5):e0126444
pubmed: 25951060
J Carcinog Mutagen. 2014;5:
pubmed: 25541596
Sci Transl Med. 2017 Aug 16;9(403):
pubmed: 28814544
Genes Chromosomes Cancer. 1997 Dec;20(4):320-8
pubmed: 9408747
J Mol Diagn. 2015 May;17(3):209-24
pubmed: 25908243
Oncogenesis. 2019 Sep 4;8(9):49
pubmed: 31484920
DNA Cell Biol. 2014 Jul;33(7):426-37
pubmed: 24628278
Clin Cancer Res. 2006 Jan 15;12(2):447-53
pubmed: 16428485
PLoS One. 2017 Aug 24;12(8):e0182954
pubmed: 28837569
Science. 2010 Oct 8;330(6001):228-31
pubmed: 20826764
Int J Biochem Cell Biol. 2000 Feb;32(2):125-37
pubmed: 10687949
Expert Rev Mol Diagn. 2019 Apr;19(4):273-276
pubmed: 30760042
Nat Med. 2004 Nov;10(11):1251-6
pubmed: 15502842
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Cancer Res Treat. 2020 Oct;52(4):1219-1228
pubmed: 32599986
J Clin Oncol. 2003 Mar 15;21(6):1035-43
pubmed: 12637468
Sci Rep. 2019 Jul 18;9(1):10426
pubmed: 31320709
Int J Gynecol Cancer. 2005 Sep-Oct;15(5):679-91
pubmed: 16174214
BMC Cancer. 2019 Jul 15;19(1):696
pubmed: 31307411
Int J Cancer. 2011 Jun 1;128(11):2572-80
pubmed: 20715113
Anticancer Res. 2011 Aug;31(8):2661-8
pubmed: 21778320
Anticancer Agents Med Chem. 2013 Feb;13(2):276-80
pubmed: 22721387
Biomed Res Int. 2015;2015:681416
pubmed: 26819954
Hum Pathol. 2013 May;44(5):734-42
pubmed: 23084584
Mol Cancer Ther. 2019 Apr;18(4):845-855
pubmed: 30824612
J Natl Cancer Inst. 2001 Oct 3;93(19):1458-64
pubmed: 11584061
Front Genet. 2018 Jun 15;9:205
pubmed: 29971090
Genome Med. 2017 Dec 22;9(1):116
pubmed: 29268796
Gastroenterology. 2008 Feb;134(2):511-22
pubmed: 18242217
Int J Gynaecol Obstet. 2008 May;101(2):205-10
pubmed: 18199437
Mod Pathol. 2006 Jun;19(6):847-53
pubmed: 16607372
Int J Gynecol Cancer. 2011 May;21(4):625-32
pubmed: 21412167
Oncotarget. 2018 Feb 22;9(20):15266-15274
pubmed: 29632642
BMC Med. 2016 Aug 24;14(1):126
pubmed: 27558279
Nat Rev Cancer. 2011 Dec 23;12(1):68-78
pubmed: 22193408
Nat Rev Clin Oncol. 2017 Sep;14(9):531-548
pubmed: 28252003
PLoS One. 2015 Dec 30;10(12):e0145754
pubmed: 26717006
Oncotarget. 2017 Sep 8;8(60):101325-101332
pubmed: 29254167
Nat Rev Cancer. 2017 Apr;17(4):223-238
pubmed: 28233803
J Ovarian Res. 2013 Jul 02;6(1):45
pubmed: 23819707
Womens Health (Lond). 2006 Jan;2(1):141-58
pubmed: 19803934
Oncotarget. 2017 Jan 24;8(4):6376-6398
pubmed: 28031527
Cancer Res Treat. 2020 Jul;52(3):779-788
pubmed: 32106643
Oral Oncol. 2003 Feb;39(2):157-62
pubmed: 12509969
Clin Cancer Res. 2012 Feb 1;18(3):869-81
pubmed: 22142828
Biomark Cancer. 2019 Jul 05;11:1179299X19860815
pubmed: 31308780
Transl Lung Cancer Res. 2016 Aug;5(4):433-5
pubmed: 27659489
J Oncol. 2010;2010:414676
pubmed: 20066160
Nat Commun. 2014;5:3156
pubmed: 24448499
Anticancer Res. 2004 Mar-Apr;24(2C):1149-57
pubmed: 15154640
Sci Transl Med. 2012 May 30;4(136):136ra68
pubmed: 22649089
Oncotarget. 2017 Jul 25;8(30):48820-48831
pubmed: 28415744
Oncogene. 1995 Oct 5;11(7):1217-28
pubmed: 7478541
Clin Chem Lab Med. 2018 Jan 26;56(2):186-197
pubmed: 28753534
Mol Diagn Ther. 2013 Jun;17(3):139-46
pubmed: 23552992
Clin Cancer Res. 1997 Jun;3(6):999-1007
pubmed: 9815777
Biomed Res Int. 2015;2015:156432
pubmed: 25954746
JCO Precis Oncol. 2019 May 3;3:
pubmed: 32914024
Tumour Biol. 2018 Feb;40(2):1010428318760342
pubmed: 29484962
J Gynecol Oncol. 2019 May;30(3):e32
pubmed: 30887755
Gynecol Oncol. 2010 Jun;117(3):429-39
pubmed: 20233625
BMC Cancer. 2019 Apr 29;19(1):398
pubmed: 31035945